Adial Pharmaceuticals
ADIL
#10837
Rank
โ‚ฌ12.08 M
Marketcap
4,60ย โ‚ฌ
Share price
36.12%
Change (1 day)
1,667.28%
Change (1 year)

EPS for Adial Pharmaceuticals (ADIL)

EPS in 2026 (TTM): -16,75ย โ‚ฌ

According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -17,63ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -10,88ย โ‚ฌ an increase over its 2024 EPS that were of -62,00ย โ‚ฌ.

EPS history for Adial Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-16,75ย โ‚ฌ54.03%
2025-10,88ย โ‚ฌ-82.46%
2024-62,00ย โ‚ฌ-24.43%
2023-82,04ย โ‚ฌ-71.68%
2022-289,66ย โ‚ฌ-51.12%
2021-592,54ย โ‚ฌ19.54%
2020-495,68ย โ‚ฌ-0%
2019-495,68ย โ‚ฌ-64.34%
2018-1.390ย โ‚ฌ1072.27%
2017-118,59ย โ‚ฌ136.68%
2016-50,11ย โ‚ฌ-56.33%
2015-114,74ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-0,05470ย โ‚ฌ-99.69% Bahamas
NRC Health
NRC
0,26ย โ‚ฌ-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA